nach oben

Intensive Care Medicine

Erschienen in:

01.02.2008 | Original

Association between urokinase haplotypes and outcome from infection-associated acute lung injury

verfasst von: John Arcaroli, Jeff Sankoff, Nianjun Liu, David B. Allison, James Maloney, Edward Abraham

Erschienen in: Intensive Care Medicine | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Abstract

Objective

Alterations in coagulation, including elevated pulmonary and systemic concentrations of urokinase, are frequent in patients with acute lung injury (ALI). Urokinase potentiates neutrophil activation and contributes to the severity of pulmonary injury in preclinical models of ALI. The objective of this study was to examine associations between polymorphisms and haplotypes of urokinase with risk for and outcomes from ALI.

Design

Prospective cohorts of healthy European-American adults and those with infection-associated ALI.

Setting

Academic medical centers participating in NIH funded studies of low tidal volume ventilation for ALI.

Patients

Controls were 175 healthy European-American subjects. Patients were 252 individuals with infection-associated ALI, prospectively followed for 60 days for mortality.

Interventions

Genetic polymorphisms and haplotypes in the urokinase gene were determined.

Measurements and main results

Six polymorphisms, rs1916341, rs2227562, rs2227564, rs2227566, rs2227571, and rs4065, defining 98% of all urokinase haplotypes, were analyzed. There were no statistically significant associations between any single urokinase polymorphism or haplotype and risk for developing ALI. In contrast, there was a statistically significant relationship between the CGCCCC haplotype and both 60-day mortality and ventilator-free days that remained present in a multivariate analysis controlling for age and sex (p = 0.033 for 60-day mortality and < 0.001 for ventilator-free days).

Conclusions

These results identify a specific urokinase haplotype as a genetic risk factor for higher mortality and more severe clinical outcome in patients with infection-associated ALI.

Nur mit Berechtigung zugänglich

Bernard GR (2005) Acute respiratory distress syndrome: a historical perspective. Am J Respir Crit Care Med 172:798–806PubMedCrossRef

Matthay MA, Zimmerman GA (2005) Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol 33:319–327PubMedCrossRef

Ware LB, Camerer E, Welty-Wolf K, Schultz MJ, Matthay MA (2006) Bench to bedside: targeting coagulation and fibrinolysis in acute lung injury. Am J Physiol Lung Cell Mol Physiol 291:L307–L311PubMedCrossRef

Ware LB, Matthay MA, Parsons PE, Thompson BT, Januzzi JL, Eisner MD (2007) Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome. Crit Care Med 35:1821–1828PubMedCrossRef

Blasi F, Carmeliet P (2002) uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 3:932–943PubMedCrossRef

Idell S (2002) Endothelium and disordered fibrin turnover in the injured lung: newly recognized pathways. Crit Care Med 30:S274–S280PubMedCrossRef

Abraham E, Gyetko MR, Kuhn K, Arcaroli J, Strassheim D, Park JS, Shetty S, Idell S (2003) Urokinase-type plasminogen activator potentiates lipopolysaccharide-induced neutrophil activation. J Immunol 170:5644–5651PubMed

van der Poll T, Levi M, Nick JA, Abraham E (2005) Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans. Am J Respir Crit Care Med 171:1125–1128PubMedCrossRef

Levi M, Schultz MJ, Rijneveld AW, van der Poll T (2003) Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia. Crit Care Med 31:S238–S242PubMedCrossRef

10.

Choi G, Schultz MJ, van Till JW, Bresser P, van der Zee JS, Boermeester MA, Levi M, van der Poll T (2004) Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection. Eur Respir J 24:786–789PubMedCrossRef

11.

Schultz MJ, Haitsma JJ, Zhang H, Slutsky AS (2006) Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia: a review. Crit Care Med 34:871–877PubMed

12.

Groeneveld AB, Kindt I, Raijmakers PG, Hack CE, Thijs LG (1997) Systemic coagulation and fibrinolysis in patients with or at risk for the adult respiratory distress syndrome. Thromb Haemost 78:1444–1449PubMed

13.

Prabhakaran P, Ware LB, White KE, Cross MT, Matthay MA, Olman MA (2003) Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am J Physiol Lung Cell Mol Physiol 285:L20–L28PubMed

14.

Idell S (2003) Coagulation, fibrinolysis, and fibrin deposition in acute lung injury. Crit Care Med 31:S213–S220PubMedCrossRef

15.

El Solh AA, Bhora M, Pineda L, Aquilina A, Abbetessa L, Berbary E (2006) Alveolar plasminogen activator inhibitor-1 predicts ARDS in aspiration pneumonitis. Intensive Care Med 32:110–115PubMedCrossRef

16.

Wang XQ, Bdeir K, Yarovoi S, Cines DB, Fang W, Abraham E (2006) Involvement of the urokinase kringle domain in lipopolysaccharide-induced acute lung injury. J Immunol 177:5550–5557PubMed

17.

Kwak S-H, Mitra S, Bdeir K, Strassheim D, Park JS, Kim JK, Idell S, Cines DL, Abraham E (2005) The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins. J Leukoc Biol 78:937–945PubMedCrossRef

18.

Irigoyen JP, Munoz-Canoves P, Montero L, Koziczak M, Nagamine Y (1999) The plasminogen activator system: biology and regulation. Cell Mol Life Sci 56:104–132PubMedCrossRef

19.

Przybylowska K, Smolarczyk K, Kulig A, Romanowicz-Makowska H, Dziki A, Ulanska J, Pander B, Blasiak J (2002). Antigen levels of the urokinase-type plasminogen activator and its gene polymorphisms in colorectal cancer. Cancer Lett 181:23–30PubMedCrossRef

20.

Majsterek I, Przybylowska K, Mlynarski W, Drzewoski J, Blasiak J (2005) Distribution of C–>T and T–>C polymorphisms of the urokinase-type plasminogen activator gene in children with type 1 diabetes mellitus and insulin resistance. Clin Exp Med 4:202–206PubMedCrossRef

21.

Ertekin-Taner N, Ronald J, Feuk L, Prince J, Tucker M, Younkin L, Hella M, Jain S, Hackett A, Scanlin L, Kelly J, Kihiko-Ehman M, Neltner M, Hersh L, Kindy M, Markesbery W, Hutton M, de Andrade M, Petersen RC, Graff-Radford N, Estus S, Brookes AJ, Younkin SG (2005) Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene. Hum Mol Genet 14:447–460PubMedCrossRef

22.

Riemenschneider M, Konta L, Friedrich P, Schwarz S, Taddei K, Neff F, Padovani A, Kolsch H, Laws SM, Klopp N, Bickeboller H, Wagenpfeil S, Mueller JC, Rosenberger A, Diehl-Schmid J, Archetti S, Lautenschlager N, Borroni B, Muller U, Illig T, Heun R, Egensperger R, Schlegel J, Forstl H, Martins RN, Kurz A (2006) A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease. Hum Mol Genet 15:2446–2456PubMedCrossRef

23.

Huang CM, Chen CL, Tsai JJ, Tsai CH, Tsai FJ (2004) Association between urokinase gene 3'-UTR T/C polymorphism and Chinese patients with rheumatoid arthritis in Taiwan. Clin Exp Rheumatol 22:219–222PubMed

24.

Begin P, Tremblay K, Daley D, Lemire M, Claveau S, Salesse C, Kacel S, Montpetit A, Becker A, Chan-Yeung M, Kozyrskyj AL, Hudson TJ, Laprise C (2007) Association of urokinase-type plasminogen activator with asthma and atopy. Am J Respir Crit Care Med 175:1109–1116PubMedCrossRef

25.

Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, Schoenfeld D, Thompson BT (2004) Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351:327–336PubMedCrossRef

26.

Scheet P, Stephens M (2006) A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet 78:629–644PubMedCrossRef

27.

Zhao J, Jin L, Xiong M (2006) Test for interaction between two unlinked loci. Am J Hum Genet 79:831–845PubMedCrossRef

28.

Zhao J, Jin L, Xiong M (2006) Nonlinear tests for genomewide association studies. Genetics 174:1529–1538PubMedCrossRef

29.

Zhao JY, Xiong MM, Huang W, Wang H, Zuo J, Wu GD, Chen Z, Qiang BQ, Zhang ML, Chen JL, Ding W, Yuan WT, Xu HY, Jin L, Li YX, Sun Q, Liu QY, Boerwinkle E, Fang FD (2005) An autosomal genomic scan for loci linked to type 2 diabetes in northern Han Chinese. J Mol Med 83:209–215PubMedCrossRef

30.

Lin DY, Zeng D, Millikan R (2005) Maximum likelihood estimation of haplotype effects and haplotype-environment interactions in association studies. Genet Epidemiol 29:299–312PubMedCrossRef

31.

Zeng D, Lin DY (2005) Estimating haplotype-disease associations with pooled genotype data. Genet Epidemiol 28:70–82PubMedCrossRef

32.

Zeng D, Lin DY, Avery CL, North KE, Bray MS (2006) Efficient semiparametric estimation of haplotype-disease associations in case–cohort and nested case–control studies. Biostatistics 7:486–502PubMedCrossRef

33.

Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425–434PubMedCrossRef

34.

Lake SL, Lyon H, Tantisira K, Silverman EK, Weiss ST, Laird NM, Schaid DJ (2003) Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 55:56–65PubMedCrossRef

35.

Guo SW, Thompson EA (1992) Performing the exact test of Hardy–Weinberg proportion for multiple alleles. Biometrics 48:361–372PubMedCrossRef

36.

Myers AJ, Marshall H, Holmans P, Compton D, Crook RJ, Mander AP, Nowotny P, Smemo S, Dunstan M, Jehu L, Wang JC, Hamshere M, Morris JC, Norton J, Chakraventy S, Tunstall N, Lovestone S, Petersen R, O'Donovan M, Jones L, Williams J, Owen MJ, Hardy J, Goate A (2004) Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD. Am J Med Genet B Neuropsychiatr Genet 124:29–37PubMedCrossRef

37.

Manocha S, Russell JA, Sutherland AM, Wattanathum A, Walley KR (2007) Fibrinogen-beta gene haplotype is associated with mortality in sepsis. J Infect 54:572–577PubMedCrossRef

38.

Arcaroli J, Fessler MB, Abraham E (2005) Genetic polymorphisms and sepsis. Shock 24:300–312PubMedCrossRef

39.

Maris NA, de Vos AF, Bresser P, van der Zee JS, Meijers JC, Lijnen HR, Levi M, Jansen HM, van der Poll T (2005) Activation of coagulation and inhibition of fibrinolysis in the lung after inhalation of lipopolysaccharide by healthy volunteers. Thromb Haemost 93:1036–1040PubMed

40.

Schultz MJ, Millo J, Levi M, Hack CE, Weverling GJ, Garrard CS, van der Poll T (2004) Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax 59:130–135PubMedCrossRef

41.

Rijneveld AW, Weijer S, Bresser P, Florquin S, Vlasuk GP, Rote WE, Spek CA, Reitsma PH, van der Zee JS, Levi M, van der Poll T (2006) Local activation of the tissue factor–factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia. Crit Care Med 34:1725–1730PubMedCrossRef

42.

Idell S (1994) Extravascular coagulation and fibrin deposition in acute lung injury. New Horiz 2:566–574PubMed

43.

Abraham E (2000) Coagulation abnormalities in acute lung injury and sepsis. Am J Respir Cell Mol Biol 22:401–404PubMed

44.

Gunther A, Mosavi P, Heinemann S, Ruppert C, Muth H, Markart P, Grimminger F, Walmrath D, Temmesfeld-Wollbruck B, Seeger W (2000) Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med 161:454–462PubMed

45.

Ware LB, Bastarache JA, Wang L (2005) Coagulation and fibrinolysis in human acute lung injury: new therapeutic targets? Keio J Med 54:142–149PubMedCrossRef

46.

Gyetko MR, Sitrin RG, Fuller JA, Todd RF, Petty H, Standiford TJ (1995) Function of the urokinase receptor (CD87) in neutrophil chemotaxis. J Leukoc Biol 58:533–538PubMed

47.

Resnati M, Guttinger M, Valcamonica S, Sidenius N, Blasi F, Fazioli F (1996) Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. Embo J 15:1572–1582PubMed

48.

Mondino A, Resnati M, Blasi F (1999) Structure and function of the urokinase receptor. Thromb Haemost [Suppl 1] 82:19–22

49.

Sitrin RG, Pan PM, Blackwood RA, Huang J Petty HR (2001) Cutting edge: evidence for a signaling partnership between urokinase receptors (CD87) and L-selectin (CD62L) in human polymorphonuclear neutrophils. J Immunol 166:4822–4825PubMed

50.

Shetty S, Bdeir K, Cines DB, Idell S (2003) Induction of plasminogen activator inhibitor-1 by urokinase in lung epithelial cells. J Biol Chem 278:18124–18131PubMedCrossRef

51.

Reuning U, Magdolen V, Hapke S, Schmitt M (2003) Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins. Biol Chem 384:1119–1131PubMedCrossRef

Titel: Association between urokinase haplotypes and outcome from infection-associated acute lung injury
verfasst von: John Arcaroli
Jeff Sankoff
Nianjun Liu
David B. Allison
James Maloney
Edward Abraham
Publikationsdatum: 01.02.2008
Verlag: Springer-Verlag
Erschienen in: Intensive Care Medicine / Ausgabe 2/2008
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-007-0930-6

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Association between urokinase haplotypes and outcome from infection-associated acute lung injury

Abstract

Objective

Design

Setting

Patients

Interventions

Measurements and main results

Conclusions

Neu im Fachgebiet AINS

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Update AINS

Springer Medizin

Abstract

Objective

Design

Setting

Patients

Interventions

Measurements and main results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2008

Do antibiotics administered at the time of central venous catheter removal interfere with the evaluation of colonization?

Announcement

Continuous and intermittent cardiac output measurement in hyperdynamic conditions: pulmonary artery catheter vs. lithium dilution technique

Fatal community-acquired pneumonia due to Staphylococcus aureus carrying Panton–Valentine leukocidin genes after a stay in Africa

Year in review in Intensive Care Medicine, 2007. I. Experimental studies. Clinical studies: brain injury and neurology, renal failure and endocrinology

Stress doses of hydrocortisone in septic shock: beneficial effects on opsonization-dependent neutrophil functions

Neu im Fachgebiet AINS

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Update AINS